NCT02578277View on ClinicalTrials.gov

Study on Effects of BMS-955176 on the Pharmacokinetics of Probe Substrates

PHASE1CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

November 9, 2015

Primary Completion Date

December 23, 2015

Study Completion Date

December 23, 2015

Conditions
HIV Infections
Interventions
DRUG

CYP and transporter probe substrates

Cocktail of CYP (cytochrome P450) and transporter probe substrates

DRUG

BMS-955176

BMS-955176

DRUG

BMS-955176 plus CYP and transporter probe substrates

BMS-955176 plus the cocktail of CYP and transporter probe substrates

Trial Locations (1)

78744

GSK Investigational Site, Austin

Sponsors

Lead Sponsor

ViiV Healthcare
All Listed Sponsors
lead

ViiV Healthcare

INDUSTRY